These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29241352)

  • 21. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
    Yoshimura B; Sato K; Sakamoto S; Tsukahara M; Yoshimura Y; So R
    Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced insomnia following short-term administration of suvorexant during aripiprazole once-monthly treatment in a patient with schizophrenia.
    Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Aug; 28():165-166. PubMed ID: 28784378
    [No Abstract]   [Full Text] [Related]  

  • 23. Aripiprazole relieves catatonia but worsens hallucination in a patient with catatonic schizophrenia.
    Lin CH; Tsai YF; Huang WL
    Asia Pac Psychiatry; 2016 Jun; 8(2):176. PubMed ID: 27062667
    [No Abstract]   [Full Text] [Related]  

  • 24. [Risperidone treatment for polydipsia and severe hyponatremia in a schizophrenic patient].
    Chhoumi M; Mrad A; Mechri A
    Therapie; 2015; 70(3):309-10. PubMed ID: 25487849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-associated psoriatic rash - a case report.
    Bujor CE; Vang T; Nielsen J; Schjerning O
    BMC Psychiatry; 2017 Jul; 17(1):242. PubMed ID: 28676105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyponatremia-associated rhabdomyolysis.
    Trimarchi H; Gonzalez J; Olivero J
    Nephron; 1999; 82(3):274-7. PubMed ID: 10396001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats.
    Horska K; Ruda-Kucerova J; Drazanova E; Karpisek M; Demlova R; Kasparek T; Kotolova H
    Neuropharmacology; 2017 Sep; 123():148-158. PubMed ID: 28595931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes of rhabdomyolysis.
    Rafool GJ
    Mayo Clin Proc; 1995 Dec; 70(12):1225. PubMed ID: 7490932
    [No Abstract]   [Full Text] [Related]  

  • 29. No association between hyponatremia and rhabdomyolysis in rats.
    Peled M; Dolkart O; Finn T; Amar E; Zeltser D
    J Emerg Med; 2014 Oct; 47(4):472-8. PubMed ID: 24485700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol.
    Parabiaghi A; Tettamanti M; D'Avanzo B; Barbato A;
    Acta Psychiatr Scand; 2016 Jan; 133(1):63-75. PubMed ID: 26252780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-resistant schizophrenia.
    Fujimoto M; Hashimoto R; Yamamori H; Yasuda Y; Ohi K; Iwatani H; Isaka Y; Takeda M
    Psychiatry Clin Neurosci; 2016 Oct; 70(10):469. PubMed ID: 27539233
    [No Abstract]   [Full Text] [Related]  

  • 33. Case report: exercise-associated hyponatremia with rhabdomyolysis during endurance exercise.
    Ellis C; Cuthill J; Hew-Butler T; George SM; Rosner MH
    Phys Sportsmed; 2009 Apr; 37(1):126-32. PubMed ID: 20048498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole-induced hypersensitivity pneumonitis.
    Gunasekaran K; Murthi S; Jennings J; Lone N
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28487307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole-Associated Acute Dystonia During Dose Reduction in Patient With Schizophrenia and Dementia: A Case Report.
    Tien Y; Huang SC
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):508-509. PubMed ID: 35788549
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
    Weiss C; Weiller E; Baker RA; Duffy RA; Gwin KK; Zhang P; McQuade RD
    Int Clin Psychopharmacol; 2018 Sep; 33(5):255-260. PubMed ID: 29878915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological Gambling and Compulsive Eating Associated with Long-Acting Injectable Aripiprazole: A Case Report.
    Golouh V; Celofiga A
    Psychiatr Danub; 2021; 33(3):373-375. PubMed ID: 34795185
    [No Abstract]   [Full Text] [Related]  

  • 38. Aripiprazole-induced transient myopia: A rare entity.
    Praveen Kumar KV; Chiranjeevi P; Alam MS
    Indian J Ophthalmol; 2018 Jan; 66(1):130-131. PubMed ID: 29283140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report.
    Rao N; Venkatasubramanian G; Korpade V; Behere R; Varambally S; Gangadhar B
    Turk Psikiyatri Derg; 2011; 22(2):123-5. PubMed ID: 21638234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two long-acting injectable antipsychotics for schizophrenia.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):152-3. PubMed ID: 26529133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.